Binex Co., Ltd. logo

Binex Co., Ltd. (053030)

Market Open
11 Aug, 06:30
KRX SM KRX SM
7,620. 00
+90
+1.1952%
313.06B Market Cap
- P/E Ratio
- Div Yield
7,722 Volume
- Eps
7,530
Previous Close
Add Transaction
Day Range
7,390 7,640
Year Range
5,500 19,200
Want to track 053030 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

053030 trading today higher at ₩7,620, an increase of 1.1952% from yesterday's close, completing a monthly increase of 0.7937% or ₩60. Over the past 12 months, 053030 stock lost -49.1661%.
053030 is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -6.7067%, based on the last three reports.
Binex Co., Ltd. has completed 3 stock splits, with the recent split occurring on May 02, 2011.
The company's stock is traded on one exchange.

053030 Chart

People also search for

Lg Chem Ltd.
278,750
+0.2698%
LG Chem Ltd.
127,600
-0.8547%
Korea Zinc Co., Ltd.
1,237,000
+0.1619%
Posco Holdings Inc.
331,750
-1.2649%
Hyundai Steel Co.
28,825
-0.2595%

Binex Co., Ltd. (053030) FAQ

What is the stock price today?

The current price is ₩7,620.00.

On which exchange is it traded?

Binex Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 053030.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 313.06B.

Has Binex Co., Ltd. ever had a stock split?

Binex Co., Ltd. had 3 splits and the recent split was on May 02, 2011.

Binex Co., Ltd. Profile

Chemicals Industry
Materials Sector
- CEO
KRX SM Exchange
KR7053030003 ISIN
South Korea Country
- Employees
- Last Dividend
2 May 2011 Last Split
- IPO Date

Overview

Binex Co., Ltd. stands as a prominent player in the pharmaceutical landscape, known for its specialization in the production and distribution of biopharmaceutical products. The company's commitment to advancing healthcare through innovation and cutting-edge research distinguishes it within the industry. Operating globally, Binex significantly influences the healthcare sector, including providers, pharmacies, and pharmaceutical retailers. Its role extends to the financial markets, where it affects the supply chain of crucial medications, thus ensuring their availability and accessibility. Through its focus on high-quality manufacturing processes and groundbreaking solutions, Binex Co., Ltd. actively contributes to the development of medical treatments and enhances patient care, affirming its position as a vital entity in the biopharmaceutical sector.

Products and Services

  • Biopharmaceutical Products

    At the core of Binex Co., Ltd.'s offering are its biopharmaceutical products, designed to meet various health requirements across a wide spectrum. These range from treatments for chronic conditions to solutions for acute illnesses, developed using sophisticated biotechnology and rigorous research practices. The company ensures these products are accessible to healthcare systems worldwide, aiding in the treatment of numerous diseases and improving the quality of life for patients globally.

  • Innovative Therapies

    Binex Co., Ltd. is also reputed for its development of innovative therapies, which embody its commitment to healthcare improvement. These therapies emerge from the company's dedicated research and development efforts, aiming at addressing unmet medical needs and pioneering new treatment paradigms. By focusing on innovation, Binex provides healthcare professionals and patients with more effective, efficient, and personalized treatment options, underscoring its impact on the future of medicine.

  • Technological Advancements in Healthcare

    The company prides itself on its technological prowess, leveraging advanced technologies to enhance the production of medications and the development of new therapies. This includes state-of-the-art manufacturing processes and research methodologies. Binex Co., Ltd.'s technology-driven approach not only streamlines its operations but also ensures the high quality and safety of its pharmaceutical products, facilitating better health outcomes for individuals worldwide.

Contact Information

Address: -
Phone: -